International Brand Names
International Brand Names by CountryFor country code abbreviations (
show table)
-
(AE) United Arab Emirates: Sebivo;
-
(AU) Australia: Sebivo;
-
(BG) Bulgaria: Sebivo;
-
(BR) Brazil: Sebivo;
-
(CN) China: Su bi fu;
-
(DE) Germany: Sebivo;
-
(ES) Spain: Sebivo;
-
(FI) Finland: Sebivo;
-
(FR) France: Sebivo;
-
(GB) United Kingdom: Sebivo;
-
(GR) Greece: Sebivo;
-
(ID) Indonesia: Sebivo;
-
(IE) Ireland: Sebivo;
-
(IL) Israel: Sebivo;
-
(IN) India: Sebivo;
-
(KE) Kenya: Sebivo;
-
(KR) Korea, Republic of: Sebibo;
-
(KW) Kuwait: Sebivo;
-
(MA) Morocco: Sebivo;
-
(NL) Netherlands: Sebivo;
-
(NO) Norway: Sebivo;
-
(PH) Philippines: Sebivo;
-
(PK) Pakistan: Hepatel | Virokalim;
-
(PL) Poland: Sebivo;
-
(PY) Paraguay: Sebivo;
-
(RU) Russian Federation: Sebivo;
-
(SA) Saudi Arabia: Sebivo;
-
(SE) Sweden: Sebivo;
-
(SI) Slovenia: Sebivo;
-
(TH) Thailand: Sebivo;
-
(TR) Turkey: Sebivo;
-
(UA) Ukraine: Sebivo;
-
(UY) Uruguay: Sebivo;
-
(ZM) Zambia: Sebivo
Pharmacologic Category
-
Antihepadnaviral, Reverse Transcriptase Inhibitor, Nucleoside (Anti-HBV)
Reported Use
Treatment of chronic hepatitis B with evidence of viral replication and active liver inflammation.
Dosage Range
Adults: Oral: 600 mg once daily.
Product Availability
Product available in various countries; not currently available in the United States.
Dosage Forms
Tablet, Oral: 600 mg
